Skip Navigation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by MARKIEWICZ, V. R.
Right arrow Articles by HOOK, J. B.
Right arrow Search for Related Content
PubMed
Right arrow Articles by MARKIEWICZ, V. R.
Right arrow Articles by HOOK, J. B.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1988 Oxford University Press

research-article

Carcinogenicity Study of Auranofin, an Orally Administered Gold Compound, in Mice

V. R. MARKIEWICZ*, L. Z. SAUNDERS{dagger}, R. J. GEUS{dagger}, B. J. PAYNE{ddagger} and J. B. HOOK{dagger},1

*Hazleton Laboratories America Inc. 9200 Leesburg Turnpike, Vienna, Virginia 22180. {dagger}Pathology and Toxicology Department, Smith Kline & French Laboratories 709 Swede/and Road, King of Prussia, Pennsylvania 19406. {ddagger} PRL, P.O. Box 1002, Alexandria, Virginia 22313

Received October 28, 1987; accepted February 8, 1988

Carcinogenicity Study of Auranofin, an Orally Administered Gold Compound, in Mice. Markiewicz, V. R., Saunders, L. Z., Geus, R. J., Payne, B. J. and Hook, J. B. (1988). Fundam Appl Toxicol. 11, 277–284. Auranofin, a gold-containing compound, was administered to Charles River CO-1 mice for 18 months to assess its possible carcinogenicity. The mice were dosed orally with 1.0,3.0, or 6.0 (increased to 9.0 on Day 294) mg/kg/day. Each dose group and each of two control groups contained 110 males and 110 females. Survival was greater than 70% at the end of the study. No effect of the treatment on neoplastic or nonneoplastic lesions was found. This is in contrast to the results reported in rats. Auranofin in rats produced a heavy metal nephropathy characterized by acute coagulative necrosis, subacute renal cortical fibrosis, chronic cytomegaly and karyomegaly, and finally renal cortical neoplasia (adenomas and adeno-carcinomas). The lack of effect of auranofin on tumor incidence in mice suggests the findings in rats may be Species specific.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.